CICC Global Fund Management Co., Ltd. reduced its holdings of INNOCARE-B (09969) by approximately 892,600 shares at a price of approximately HK$18.86 per share.

08/08/2025

On August 5, CSC Global Fund Management Limited reduced its holding of Nuocheng Jianhua-B (09969) by 892,639 shares, with a price of HK$18.8587 per share, totaling approximately HK$168.34 million.

The latest data from the Hong Kong Stock Exchange shows that on August 5, China Universal Global Fund Management Co., Ltd. reduced its holdings of INNOCARE-B (09969) by 892,639 shares, at a price of HK$18.8587 per share, for a total amount of approximately HK$16.834 million. After the reduction, the latest number of shares held is 74,671.86 million, with a latest shareholding ratio of 4.99%.

New Stock News | OmniVision Integrated Circuits Group, Inc. (603501.SH) plans to IPO in Hong Kong. The China Securities Regulatory Commission requires an explanation for reasons of inconsistency in the identification of the controlling shareholder in the filing materials.

China Yuchai International Limited (CYD.US) reports strong revenue and profit growth in the first half of the year, with pre-market trading up nearly 9%.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The employee stock ownership plan plans to reduce its shareholding by no more than 3%.

China Yuchai International Limited (CYD.US) reports strong revenue and profit growth in the first half of the year, with pre-market trading up nearly 9%.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The employee stock ownership plan plans to reduce its shareholding by no more than 3%.